Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of p53 allosteric agent and its application as medicine

A p53 and drug technology, applied in the field of pharmacology, can solve the problems of poor stability of drugs, achieve strong affinity, inhibit tumor proliferation, and broad development prospects

Inactive Publication Date: 2020-10-16
CHINA PHARM UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

APR-246 (PRIMA-1MET), a new compound designed by PRIMA-1, is currently in phase II clinical research, but APR-246 (PRIMA-1MET) has also revealed poor drug stability and certain liver toxicity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of p53 allosteric agent and its application as medicine
  • A kind of preparation method of p53 allosteric agent and its application as medicine
  • A kind of preparation method of p53 allosteric agent and its application as medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] The compound I structure of the novel p53 allosteric agent is as follows:

[0031]

[0032] The synthetic route of compound I is as follows

[0033]

[0034] The synthetic method of compound I comprises the steps:

[0035] By amide reaction: at room temperature, the reactant 3-aminobenzoic acid methyl ester (20g, 0.13mol) and maleic anhydride (12.9g, 0.13mol) were dissolved in 80mL acetic anhydride (acetic anhydride as solvent) and stirred at room temperature for 2h, then Sodium acetate (1.43 g, 0.10 mol) was added. The mixture was heated to reflux at 120°C for 3 hours. After cooling down to room temperature, 300ml of water was poured into the reaction solution, extracted twice with ethyl acetate (150ml x 2), the organic layer was washed with 50ml of brine, dried over sodium sulfate, concentrated by rotary evaporator, and subjected to column chromatography on silica gel. Purified with petroleum ether:ethyl acetate=10:1 (eluent ratio PE:EA=10:1) to obtain white ...

Embodiment 2

[0039] The synthetic method of embodiment 1 has carried out condition experiment:

[0040] (1) Condition optimization: compound I was synthesized with the synthetic method of Example 1, the difference being that the molar ratio of 3-aminobenzoic acid methyl ester, maleic anhydride, and sodium acetate was 1:1:1.5; the conditions of heating and reflux For: stirring at room temperature overnight; the result is no product.

[0041] (2) Condition optimization: Compound I is synthesized with the synthetic method of Example 1, the difference is that: the molar ratio of methyl 3-aminobenzoate, maleic anhydride, and sodium acetate is 1:1:1; the conditions of heating and reflux For: stirring at 80°C overnight, LCMS checks that the purity of compound I is about 49%.

[0042] (3) Condition optimization: compound I is synthesized with the synthetic method of Example 1, the difference is that: the molar ratio of methyl 3-aminobenzoate, maleic anhydride, and sodium acetate is 1:1:1; the con...

Embodiment 3

[0047] Effect of compound Ⅰ on p53 mutant cell line H1299

[0048] Experimental method: Cell viability was determined by using MTT to test the effect of compound Ⅰ on the proliferation of NCI-H1299 human non-small cell lung cancer cells in vitro, and the cell survival rate was calculated = (administration group-blank group) / (solvent group-blank group).

[0049] Experimental principle: MTT method, also known as MTT colorimetric method, is a common method for detecting cell survival and growth. The detection principle is that succinate dehydrogenase in the mitochondria of living cells can reduce exogenous MTT to water-insoluble blue-purple crystalline formazan (Formazan) and deposit in the cells, while dead cells do not have this function. Dimethyl sulfoxide (DMSO) can dissolve formazan in cells, and its light absorption value is measured at a wavelength of 570nm with an enzyme-linked immunosorbent detector, which can indirectly reflect the number of living cells. Within a certai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of tumor related medicines, and particularly relates to a method for preparing a novel p53 allosteric enzyme and an application of the novel p53 allosteric enzyme asmedicines. The novel p53 allosteric enzyme is prepared from compound I (2-(2,5-dioxo-2,5-dihydro-1H-pyrrole-1-ol)-methyl benzoate). In-vitro cell model experiments prove that the compound I has the same effect of inhibiting tumor proliferation as that of PRIMA-1, and microscale thermophoresis (MST) experiments indicate that the compound has a relatively strong affinity on p53 protein. Therefore,the compound I or pharmaceutically acceptable ester of the compound I or medicinal salt of the compound I can be used for treating or preventing p53 protein mutation and related diseases, and has a wide development prospect.

Description

technical field [0001] The invention relates to the field of pharmacology related to tumors, in particular to a preparation method of a novel p53 allosteric agent and its use as a medicine. Background technique [0002] Malignant tumors are frequently occurring diseases that seriously threaten human health and quality of life. According to statistics in 2015, about 90.5 million people in the world suffer from malignant tumors, and 14.1 million new cases of cancer patients are added every year. With the provision of people's living standards in our country, the number of patients with cancer and the number of new cases each year are increasing year by year with the arrival of population aging. [0003] The p53 protein was discovered in 1979 while studying the multiple papillomavirus. With the advancement of science and technology, the in-depth research on p53 protein and TP53 gene, the role of p53 protein in the occurrence and development of tumors is becoming more and more...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D207/452A61P35/00
CPCA61P35/00C07D207/452
Inventor 王玉平吴亮江经纬张停婷刘本全贺慧勤丁赣程张陆勇
Owner CHINA PHARM UNIV